These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8302105)

  • 1. The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients.
    de Lissovoy G; Powe NR; Griffiths RI; Watson AJ; Anderson GF; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
    Med Care; 1994 Feb; 32(2):130-40. PubMed ID: 8302105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
    Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
    JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients.
    Powe NR; Griffiths RI; Anderson GF; de Lissovoy G; Watson AJ; Greer JW; Herbert RJ; Whelton PK
    Am J Kidney Dis; 1993 Oct; 22(4):557-67. PubMed ID: 8213796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ownership and changes in hospital inefficiency, 1986-1991.
    McKay NL; Deily ME; Dorner FH
    Inquiry; 2002-2003 Winter; 39(4):388-99. PubMed ID: 12638713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
    Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
    Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profit-making in the treatment of chronic kidney disease: truth and consequences.
    Garg PP; Powe NR
    Semin Dial; 2001; 14(3):153-6. PubMed ID: 11422916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of care and administration at for-profit and other hospitals in the United States.
    Woolhandler S; Himmelstein DU
    N Engl J Med; 1997 Mar; 336(11):769-74. PubMed ID: 9052656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital ownership and cost and quality of care: is there a dime's worth of difference?
    Sloan FA; Picone GA; Taylor DH; Chou SY
    J Health Econ; 2001 Jan; 20(1):1-21. PubMed ID: 11148866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hospital conversions to for-profit status and clinical and economic outcomes.
    Joynt KE; Orav EJ; Jha AK
    JAMA; 2014 Oct 22-29; 312(16):1644-52. PubMed ID: 25335146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between for-profit hospital ownership and increased Medicare spending.
    Silverman EM; Skinner JS; Fisher ES
    N Engl J Med; 1999 Aug; 341(6):420-6. PubMed ID: 10432327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are for-profit hospital conversions harmful to patients and to Medicare?
    Picone G; Chou SY; Sloan F
    Rand J Econ; 2002; 33(3):507-23. PubMed ID: 12585305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.
    Powe NR; Griffiths RI; de Lissovoy G; Anderson GF; Watson AJ; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
    JAMA; 1992 Sep; 268(11):1434-40. PubMed ID: 1512912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.
    Griffiths RI; Powe NR; Gaskin DJ; Anderson GF; de Lissovoy GV; Whelton PK
    Health Serv Res; 1994 Oct; 29(4):473-87. PubMed ID: 7928373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Costs of Care in the Operating Room.
    Childers CP; Maggard-Gibbons M
    JAMA Surg; 2018 Apr; 153(4):e176233. PubMed ID: 29490366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
    Garg PP; Frick KD; Diener-West M; Powe NR
    N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of hospital ownership on medical productivity.
    Kessler DP; McClellan MB
    Rand J Econ; 2002; 33(3):488-506. PubMed ID: 12585304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.
    Hirth RA; Held PJ; Orzol SM; Dor A
    Health Serv Res; 1999 Feb; 33(6):1567-92. PubMed ID: 10029498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ownership difference in relative performance of rehabilitation specialty hospitals.
    McCue MJ; Thompson JM
    Arch Phys Med Rehabil; 1995 May; 76(5):413-8. PubMed ID: 7741610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.
    Duh MS; Mody SH; McKenzie RS; Lefebvre P; Gosselin A; Bookhart BK; Piech CT
    Drugs Aging; 2006; 23(12):969-76. PubMed ID: 17154661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.